SCRI FCS North- Ocala — Ocala, Florida

SCRI FCS North- Ocala is a clinical research site located in Ocala, Florida, United States 34474.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI FCS North- Ocala has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.

Sponsors: Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI FCS North- Ocala?

SCRI FCS North- Ocala has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI FCS North- Ocala conducted?

SCRI FCS North- Ocala has 1 clinical trials on record, with 1 currently active. Their work covers HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.

Is SCRI FCS North- Ocala accredited by Crixeo Health?

SCRI FCS North- Ocala has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI FCS North- Ocala?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.